Drug profile · INN
cefmenoxime hydrochloride
CEFMAX
cefmenoxime hydrochloride (CEFMAX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefmenoxime hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefmenoxime hydrochloride (CEFMAX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefmenoxime hydrochloride?
cefmenoxime hydrochloride (CEFMAX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefmenoxime hydrochloride?
CEFMAX is a marketed brand name for cefmenoxime hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefmenoxime hydrochloride?
cefmenoxime hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.